DIA 2025 Global Annual Meeting

Component Type: Forum
Level: Intermediate

This forum will address need for a global development strategy aimed at enhancing patient access to new drugs and maximizing business opportunities in Japan. The panelists will consist of members from pharma industry associations, agency and academia

Learning Objectives

Maximize value of innovative products for the global market including Japan; Apply learnings to clinical development strategy to expand target patients and market effectively; Enhance access to innovative drugs for children and patients with rare diseases; Influence regulators, industry, and trial sites to improve the local environment and reduce burdens in global simultaneous development.

Chair

Toshiharu Sano, RPh